These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36118385)

  • 1. Epidemiological Study of Triple-Negative Breast Cancer Patients in North Indian Population: a Hospital-Based Study.
    Gupta M; Khanna S; Kumar M; Kar AG; Gupta SK
    Indian J Surg Oncol; 2017 Sep; 8(3):279-283. PubMed ID: 36118385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Markers in Breast Cancer: A Cross-Sectional Study on Triple-Negative Breast Cancer in a Rural Tertiary Care Hospital.
    Ba R; Karanam VPK; Mundada AB
    Cureus; 2021 Nov; 13(11):e19486. PubMed ID: 34912627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients.
    Mosalpuria K; Hall C; Krishnamurthy S; Lodhi A; Hallman DM; Baraniuk MS; Bhattacharyya A; Lucci A
    Mol Clin Oncol; 2014 Sep; 2(5):845-850. PubMed ID: 25054056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience.
    Der EM; Gyasi RK; Tettey Y; Edusei L; Bayor MT; Jiagge E; Gyakobo M; Merajver SD; Newman LA
    Breast J; 2015; 21(6):627-33. PubMed ID: 26547900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological comparison of triple negative breast cancers with non-triple negative breast cancers in a hospital in North India.
    Nabi MG; Ahangar A; Wahid MA; Kuchay S
    Niger J Clin Pract; 2015; 18(3):381-6. PubMed ID: 25772923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
    Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
    Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple negative breast cancer in people of North East India: critical insights gained at a regional cancer centre.
    Sharma M; Sharma JD; Sarma A; Ahmed S; Kataki AC; Saxena R; Sharma D
    Asian Pac J Cancer Prev; 2014; 15(11):4507-11. PubMed ID: 24969877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
    Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
    World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological, Treatment and Event-Free Survival Characteristics in a Moroccan Population of Triple-Negative Breast Cancer.
    Mouh FZ; Slaoui M; Razine R; El Mzibri M; Amrani M
    Breast Cancer (Auckl); 2020; 14():1178223420906428. PubMed ID: 32425539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?
    Albergaria A; Ricardo S; Milanezi F; Carneiro V; Amendoeira I; Vieira D; Cameselle-Teijeiro J; Schmitt F
    BMC Cancer; 2011 Jul; 11():299. PubMed ID: 21762477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India.
    Dogra A; Doval DC; Sardana M; Chedi SK; Mehta A
    Asian Pac J Cancer Prev; 2014; 15(24):10577-83. PubMed ID: 25605142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate Receptor Alpha Immunohistochemistry in Cytology Specimens of Metastatic Breast Carcinoma.
    Sheikh UN; Cohen C; Siddiqui MT
    Acta Cytol; 2015; 59(4):298-304. PubMed ID: 26413911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of male triple negative breast cancer: A population-based study.
    Ghani S; Sochat M; Luo J; Tao Y; Ademuyiwa F
    Breast J; 2020 Sep; 26(9):1748-1755. PubMed ID: 32856383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Expression Of Matrix Metalloproteinase-1 (MMP-1) in Different Types Of Breast Carcinoma And Its Comparison With ER/PER and HER2/neu.
    Shamsi FB; Anwar A; Lail RA; Bukhari MH; Naseem N; Nagi AH
    J Ayub Med Coll Abbottabad; 2022; 34(1):12-16. PubMed ID: 35466619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells.
    Sommaggio R; Cappuzzello E; Dalla Pietà A; Tosi A; Palmerini P; Carpanese D; Nicolè L; Rosato A
    Oncoimmunology; 2020 Jun; 9(1):1777046. PubMed ID: 32923140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple negative breast cancer: an Indian perspective.
    Akhtar M; Dasgupta S; Rangwala M
    Breast Cancer (Dove Med Press); 2015; 7():239-43. PubMed ID: 26316816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between triple-negative breast cancer and prognosis of patients receiving breast-conserving treatment.
    Mu L; Liu Y; Xiao M; Liu W; Liu M; Wang X
    Oncol Lett; 2017 Dec; 14(6):7862-7872. PubMed ID: 29250179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.